Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_540_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
86 Мб
Скачать
108
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
40. Elliott CL, Brennand JE, Calder AA.The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol. 1998;92:804–9.
41. Stenlund G, Aedo AR, et al. Induction of labor with mifepristone: A randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand. 1999;78:793–8.
42. Lockwood AE, Dische MR, etal. Fetal bronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991;325:669–74.
43. Iams D, McGregor JA, et al. Fetal bronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol. 1995;173:141–5.
44. Oshiro B, Edwin S, Silver R.Human bronectin and human tenascin production in human amnion cells. J Soc Gynecol Investig. 1996;3:351A.
45. King L, MacDonald P, Casey ML. Regulation of tissue inhibitor of metalloproteinase-1 (TIMP-
1) in human amnion. J Soc Gynecol Investig. 1996;3:232A.
46. Vadillo-Ortega A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies com­plicated by premature rupture of membranes. Am J Obstet Gynecol. 1996;174:1371–6.
47. Maymon R, Pacora P, et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rup­ture of membranes. Am J Obstet Gynecol. 2000;183:914–20.
48. Athayde SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 1998;79:1248–53.
49. Helmig R, Espinoza J, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prela­bor rupture of membranes, parturition and intra­amniotic infection. J Matern Fetal Neonatal Med. 2002;12:237–46.
50. Everts V, van der Zee E, Creemers L, Beertsen W.Phagocytosis and intracellular digestion of colla­gen, its role in turnover and remodelling. Histochem J. 1996;28:229–45.
51. Bennett MG, Myatt LPE.The effects of lipoxygenase metabolites of arachidonic acid on human myome­trial contractility. Prostaglandins. 1987;33:837–44.
52. Wiqvist B, Wikland M, et al. Prostaglandins and uterine contractility. Acta Obstet Gynecol Scand. 1983;113(Suppl):23–9.
53. Calder AA, Greer IA.Pharmacological modulation of cervical compliance in the rst and second trimes­ters of pregnancy. Semin Perinatol. 1991;15:162–72.
54. Rajabi M, Solomon S, Poole AR.Hormonal regu­lation of interstitial collagenase in the uterine cer­vix of the pregnant guinea pig. Endocrinology. 1991;128:863–71.
55. Mohan AR, Loudon JA, Bennett PR.Molecular and biochemical mechanisms of preterm labour. Semin Fetal Neonatal. 2004;9:437–44.
56. Myatt L, Lye SJ. Expression, localization and function of prostaglandin receptors in myome­trium. Prostaglandins Leukot Essent Fatty Acids. 2004;70:137–48.
57. Olson D.The role of prostaglandins in the initiation of parturition. Best Pract Res Clin Obstet Gynaecol. 2003;17:717–30.
58. Denison FC, Calder AA, Kelly RW. The action of prostaglandin E2on the human cervix: stimulation of interleukin 8 and inhibition of secretory leu­cocyte protease inhibitor. Am J Obstet Gynecol. 1999;180:614–20.
59. Yoshida N, Itoh H, et al. Prostaglandin F(2alpha), cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical broblast cells. Mol Hum Reprod. 2002;8:861–7.
60. Madsen T, Ku CY, et al. Prostaglandins differen­tially modulate progesterone receptor-A and -B expression in human myometrial cells: Evidence for prostaglandin- induced functional progesterone with­drawal. J Clin Endocrinol Metab. 2004;89:1010–3.
61. Mesiano S, Welsh TN.Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol. 2007;18:321.
62. Burd I, Balakrishnan B, Kannan S.Models of fetal brain injury, intrauterine inammation, and preterm birth. Am J Reprod Immunol. 2012;67:287.
63. Mercer RL, Meis PJ, etal. The preterm prediction study: prediction of preterm premature rupture of membranes through clinical ndings and ancillary testing. Am J Obstet Gynecol. 2000;183:738–45.
64. Menon R.Oxidative stress damage as a detrimental factor in preterm birth pathology. Front Immunol. 2014;5:567.
65. Dutta EH, Behnia F, Boldogh I, Saade GR, Taylor BD, Kacerovský M, etal. Oxidative stress damage­associated molecular signaling pathways differ­entiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod. 2015;22:143.
66. Pierce J, Jacobson P, Benedetti E, Peterson E, Phibbs J, Preslar A, etal. Collection and characterization of amniotic uid from scheduled C-section deliveries. Cell Tissue Bank. 2016;17:413.
67. Martinez-Varea A, Romero R, Xu Y, Miller D, Ahmed AI, Chaemsaithong P, etal. Clinical chorio­amnionitis at term VII: the amniotic uid cellular immune response. J Perinat Med. 2017;45:523.
68. Gomez-Lopez N, Romero R, Xu Y, Leng Y, Garcia­Flores V, Miller D, etal. Are amniotic uid neutro­phils in women with intraamniotic infection and/ or inammation of fetal or maternal origin? Am J Obstet Gynecol. 2017;217:693.e1.
69. Lee SD, Kim MR, Hwang PG, Sup SS, Hyun YB, Kim CJ. Chorionic plate vessels as an ori­gin of amniotic uid neutrophils. Pathol Int. 2004;54(7):516–22.
70. Bošnjak A, Relja T, Vučićević-Boras V, Plasaj H, Plančak D. Pre-term delivery and periodontal dis-
References
https://t.me/medicina_free
109
ease: a case-control study from Croatia. J Clin Periodontol. 2006;33:710.
71. Mueller-Heubach DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol. 1990;75:622–6.
72. Meis RL, Mercer B, et al. The preterm prediction study: signicance of vaginal infections. Am J Obstet Gynecol. 1995;173:1231–5.
73. Goldenberg RL, Hauth JC, Andrews WW.Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500–7.
74. Onderdonk AB, Hecht JL, McElrath TF, Delaney ML, Allred EN, Leviton A.Colonization of second­trimester placenta parenchyma. Am J Obstet Gynecol. 2008;199:52.e1.
75. Yoon R, Lim JH, et al. The clinical signicance of detecting ureaplasma urealyticum by the poly­merase chain reaction in the amniotic uid of patients with preterm labor. Am J Obstet Gynecol. 2003;189:919–24.
76. Cassell W, Hauth J, etal. Isolation of microorgan­isms from the chorioamnion is twice that from amni­otic uid at cesarean delivery in women with intact membranes. Am J Obstet Gynecol. 1993;168:424.
77. Galask RP, Varner MW, Rosemarie Petzold C, Wilbur SL.Bacterial attachment to the chorioamniotic mem­branes. Am J Obstet Gynecol. 1984;148(7):915–28.
78. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol. 1988;31:553–84.
79. Park CW, Yoon BH, Park JS, Jun JK.A fetal and an intra-amniotic inammatory response is more severe in preterm labor than in preterm PROM in the con­text of funisitis: unexpected observation in human gestations. PloS One. 2013;8:e62521.
80. Park CW, Park JS, Moon KC, Jun JK, Yoon BH.Preterm labor and preterm premature rupture of membranes have a different pattern in the involved compartments of acute histologoic chorioamnion­itis and/or funisitis: patho-physiologic implication related to different clinical manifestations. Pathol Int. 2016;66:325–32.
81. Gonçalves LF, Romero R, Chaiworapongsa T. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev. 2002;8:3–13.
82. Musilova R, Pliskova L, etal. Intraamniotic inam­mation in women with preterm prelabor rupture of membranes. PloS One. 2015;10(7):e0133929.
83. Romero J, Chaiworapongsa T, et al. Sterile intra­amniotic inammation in a symptomatic patients with a sonographic short cervix: prevalence and clinical signicance. J Matern Fetal Neonatal Med. 2015;28:1343–59.
84. Robbins JR, Bakardjiev AI.Pathogens and the pla­cental fortress. Curr Opin Microbiol. 2012;15:36–43.
85. Madianos PN, Bobetsis YA, Offenbacher S.Adverse pregnancy outcomes (APOs) and periodontal dis­ease: Pathogenic mechanisms. J Clin Periodontol. 2013;40(Suppl 1):S170–80.
86. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma
C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol. 2005;162:1108–13.
87. Tjoa ML, Van Vugt JMG, Go ATJJ, Blankenstein MA, Oudejans CBM, Van Wijk IJ. Elevated C-reactive protein levels during rst trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003;59:29–37.
88. Lei H, Furth EE, Kalluri R, Chiou T, Tilly KI, Tilly JL, etal. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Investig. 1996;98:1971.
89. Hirsch Y, Mahendroo MEF. Signaling via the type I IL-1 and TNF receptors is necessary for bacteri­ally induced preterm labor in a murine model. Am J Obstet Gynecol. 2006;194:1334–40.
90. Van Meir C, Ramirez M, Matthews S, Calder A, Keirse M, Challis J.Chorionic prostaglandin catabo­lism is decreased in the lower uterine segment with term labour. Placenta. 1997;18(2–3):109–14.
91. Vanderhoeven JP, Bierle CJ, Kapur RP, McAdams RM, Beyer RP, Bammler TK, et al. Group B Streptococcal Infection of the Choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: a pathway to membrane weak­ening. PLoS Pathog. 2014;10(3):e1003920.
92. Diddle AW. Trauma and interuption of pregnancy. Tex State J Med. 1948;44:520–4.
93. Iliodromiti Z, Antonakopoulos N, Sifakis S, Tsikouras P, Daniilidis A, Dafopoulos K, et al. Endocrine, paracrine, and autocrine placental media­tors in labor. Hormones. 2012;11:361–75.
94. Desta M. Low birth weight and adverse perinatal outcomes. In: Childbirth. London: IntechOpen;
2019.
95. Wadhwa PD, Entringer S, Buss C, Lu MC. The Contribution of maternal stress to preterm birth: issues and considerations. Clin Perinatol. 2011;38:351–84.
96. Sipilä P, Hartikainen-Sorri AL, Oja H, Von Wendt L.Perinatal outcome of pregnancies complicated by vaginal bleeding. BJOG. 1992;99:959.
97. Naeye R. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet Gynecol. 1983;61:210–6.
98. Lockwood CJ, Krikun G, Schatz F.The decidua reg­ulates hemostasis in the human endometrium. Semin Reprod Endocrinol. 1999;17:45–51.
99. Lockwood CJ, Schatz F. A biological model for the regulation of peri-implantational hemosta­sis and menstruation. J Soc Gynecol Investig. 1996;3:159–65.
100. Mackenzie F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol. 2004;191:1996–2001.
101. Rosen F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture
110
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
of the membranes. J Matern Fetal Neonatal Med. 2002;11:11–7.
102. Stephenson CD, Lockwood CJ, Ma Y, Guller S. Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. J Matern Fetal Neonatal Med. 2005;18:17–22.
103. Lockwood P, Arcuri F, et al. Mechanisms of abruption- induced premature rupture of the fetal membranes: thrombinenhanced interleu­kin- 8 expression in term decidua. Am J Pathol. 2005;167:1443–9.
104. Lathbury LJ, Salamonsen LA.In vitro studies of the potential role of neutrophils in the process of men­struation. Mol Hum Reprod. 2000;6:899–906.
105. Phillippe M, Chien EK.Intracellular signaling and phasic myometrial contractions. J Soc Gynecol Investig. 1998;5:169–77.
106. Ananth CV, Oyelese Y, Srinivas N, Yeo L, Vintzileos AM. Preterm premature rupture of membranes, intrauterine infection, and oligohydramnios: Risk factors for placental abruption. Obstet Gynecol. 2004;104:71.
107. Nath CA, Ananth CV, Smulian JC, Shen-Schwarz S, Kaminsky L. Histologic evidence of inamma­tion and risk of placental abruption. Am J Obstet Gynecol. 2007;197:319.e1.
108. Yaron Y, Lessing JB, Peyser MR. Abruptio pla­centae associated with perforated appendicitis and generalized peritonitis. Am J Obstet Gynecol. 1992;166:14–5.
109. Darby MJ, Caritis SN, Shen-Schwarz S. Placental abruption in the preterm gestation: an asso­ciation with chorioamnionitis. Obstet Gynecol. 1989;74:88–92.
110. Pagliari M.On an unusual case of uterine apoplexy preceded by an acute necrosis of the pancreas. Quad Clin Ostet Ginecol. 1962;17:589–94.
111. Cheang CU, Ho SW, Tee YT, Su CF, Chen GD. Acute necrotizing pancreatitis complicating uteroplacental apoplexy. Taiwan J Obstet Gynecol. 2007;46(1):64–7.
112. Xu L, Lin N, Zhang Y, Al E.Expression of adhesion molecule E–selectin in placenta tissues of pregnant rats with acute pancreatitis. Chin J Pathophysiol. 2011;27:1781–5.
113. Zuo T, Yu J, Wang WX, Zhao KL, Chen C, Deng WH, etal. Mitogen-activated protein kinases are activated in placental injury in rat model of acute pancreatitis in pregnancy. Pancreas. 2016;45(6):850–7.
114. Abbasi N, Patenaude V, Abenhaim HA.Evaluation of obstetrical and fetal outcomes in pregnancies complicated by acute appendicitis. Arch Gynecol Obstet. 2014;290:661–7.
115. Blaakaer J, Wilken-Jensen C, Petersen K, Møller B. Abruptio placentae as complication to acute appendicitis. Int J Gynaecol Obstet. 1989;29(2):179–80.
116. Klatsky PC, Cronbach EJ, Shahine LK, Caughey AB.Abruptio placentae in the setting of an atypical
presentation of acute appendicitis: a case report. J Reprod Med. 2008;53(2):129–31.
117. Gustowski A, Grabiec M, Graczykowski J. Acute appendicitis in pregnancy complicated by peritoni­tis and the onset of detachment of normally situated placenta. Wiad Lek. 1987;40(13):907–10.
118. Phillippe M, Elovitz M, Saunders T. Thrombin­stimulated uterine contractions in the pregnant and nonpregnant rat. J Soc Gynecol Investig. 2001;8:260.
119. Elovitz MA, Ascher-Landsberg J, Saunders T, Phillippe M.The mechanisms underlying the stim­ulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol. 2000;144(Suppl
1):S11–9.
120. Mehraban SS, Lagodka S, Kydd J, Mehraban S, Cabbad M, Chendrasekhar A, etal. Predictive risk factors of adverse perinatal outcomes following blunt abdominal trauma in pregnancy. J Matern Fetal Neonatal Med. 2021;35:8929.
121. Hendler RL, Mercer BM, etal. The preterm predic­tion study: association between maternal body mass index (BMI) and spontaneous preterm birth. Am J Obstet Gynecol. 2005;192:882–6.
122. Tamura RL, Freeberg LE, et al. Maternal serum folate and zinc concentrations and their rela­tionship to pregnancy outcome. Am J Clin Nutr. 1992;56:365–70.
123. Scholl T. Iron status during pregnancy: setting the stage for motherand infant. Am J Clin Nutr. 2005;81:1218S–22S.
124. Neggers Y, Goldenberg RL.Some thoughts on body mass index, micronutrient intakes and pregnancy outcome. J Nutr. 2003;133:1737S–40S.
125. Sellers HT, Mitchell MD, etal. Raised prostaglan­din levels in the third stage of labo. Am J Obstet Gynecol. 1982;144:209–12.
126. Casey ML, MacDonald PC.Biomolecular processes in the initiation of parturition: decidual activation. Clin Obstet Gynecol. 1988;31:533–52.
127. Matsumoto N, Yoshida M, etal. The prostaglandin E2 and F2 alpha receptor genes are expressed in human myometrium and are down-regulated dur­ing pregnancy. Biochem Biophys Res Commun. 1997;238:838–41.
128. Brodt-Eppley J, Myatt L.Prostaglandin receptors in lower uterine segment myometrium during gestation and labor. Obstet Gynecol. 1999;93:89–93.
129. Preterm Labour: Pathogenesis & Maternal Complications | Calgary Guide [Internet].
https://calgaryguide.ucalgary.ca/preterm- labour­pathogenesis- maternal- complications/. Accessed
10 Sep 2022.
130. Ayer JB.A case of idiopathic peritonitis complicat­ing labor. Boston Med Surg J. 1876;44(21):591–3.
131. Arias F, Tomich P. Etiology and outcome of low birth weight and preterm infants. Obstet Gynecol. 1982;60:277–81.
132. Moore JD, Creasy RK, etal. Diurnal and gestational patterns of uterine activity in normal human preg­nancy. Obstet Gynecol. 1994;83:517–23.
References
https://t.me/medicina_free
111
133. Nageotte W, Porto M, etal. Quantitation of uterine activity preceding preterm, term, and postterm labor. Am J Obstet Gynecol. 1988;158:1254–9.
134. Iams RB, Thom EA, etal. Frequency of uterine con­tractions and the risk of spontaneous preterm deliv­ery. N Engl J Med. 2002;346:250–5.
135. Newman JD, Das A, et al. A prospective masked observational study of uterine contraction frequency in twins. Am J Obstet Gynecol. 2006;195:1564–70.
136. Huras H, Ossowski P, Jach R, Reron A.Usefulness of marking alkaline phosphatase and C-reactive pro­tein in monitoring the risk of preterm delivery. Med Sci Monit. 2011;17:CR657–62.
137. Shahshahan Z, Iravani H.Comparison of CRP and ALK-P serum levels in prediction of preterm deliv­ery. Adv Biomed Res. 2016;5:17.
138. Hassan R, Hendler I, et al. A sonographic short cervix as the only clinical manifestation of intra­amniotic infection. J Perinat Med. 2006;34:13–9.
139. Gomez R, Nien JK, etal. A short cervix in women with preterm labor and intact membranes: a risk fac­tor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 2005;192:678–89.
140. Romero CM, Athanassiadis AP, etal. The relation­ship between acute inammatory lesions of the pre­term placenta and amniotic uid microbiology. Am J Obstet Gynecol. 1992;166:1382–8.
141. Morgan T.Placental insufciency is a leading cause of preterm labor. Neoreviews. 2014;15:518–25.
142. Berghella V, Ness A, Bega G, Berghella M.Cervical sonography in women with symptoms of pre­term labor. Obstet Gynecol Clin North Am. 2005;32:383–96.
143. Navathe R, Berghella V. Tocolysis for acute pre­term labor: where have we been, where are we now, and where are we going? Am J Perinatol. 2016;33:229–35.
144. Goldenberg R. The management of preterm labor. Obstet Gynecol. 2002;100:1020–37.
145. Korenbrot LH, Laros RK Jr. The cost effectiveness of stopping preterm labor with beta-adrenergic treat­ment. N Engl J Med. 1984;310:691–6.
146. Raju BM, Burcheld DJ, Joseph GF Jr. Periviable birth: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and. Obstet Gynecol. 2014;123:1083–96.
147. Crowther JP, Verkuyl DAA, etal. Preterm labour in twin pregnancies: can it be prevented by hospital admission? BJOG. 1989;96:850–3.
148. Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M.Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. Am J Obstet Gynecol. 2006;194:617.
149. Simcox WT, Seed PT, etal. Prophylactic antibiot­ics for the prevention of preterm birth in women at risk: a meta-analysis. Aust N Z J Obstet Gynaecol. 2007;47:367–77.
150. Mercer M, Thurnau GR, etal. Antibiotic therapy for reduction of infant morbidity after preterm prema­ture rupture of the membranes: a randomized con­trolled trial. JAMA. 1997;278:989–95.
151. Kenyon DJ, Tarnow-Mordi W, et al. Broad spec­trum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomized trial. Lancet. 2001;357:979–88.
152. Lamont RF, Duncan SL, Mandal D, Bassett P.Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract ora. Obstet Gynecol. 2003;101:516–22.
153. Kiss H, Husslein P, Petricevic L. Prospective ran­domised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ. 2004;329:371–6.
154. Nakano K, Kishi K, et al. Clindamycin modu­lates inammatory-cytokine induction in lipopolysaccharide- stimulated mouse peritoneal macrophages. Antimicrob Agents Chemother. 2003;47:363–7.
155. Del Rosso JQ, Schmidt NF. A review of the anti­inammatory properties of clindamycin in the treat­ment of acne vulgaris. Cutis. 2010;85:15–24.
156. Viniker D. Hypothesis on the role of sub-clinical bacteria of the endometrium (bacteria endometria­lis) in gynaecological and obstetric enigmas. Hum Reprod Update. 1999;5:373–85.
157. Rosenstein DJ, Lamont RF, et al. Effect of intra­vaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial ora of pregnant women. Infect Dis Obstet Gynecol. 2000;8:158–65.
158. Kenyon SL, Tarnow-Mordi W, Taylor DJ. Broad­spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet. 2001;357:989–94.
159. Kenyon K, Jones DR, et al. Childhood out­comes after prescription of antibiotics to preg­nant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372:1319–27.
160. Thomas M, Price D. Prenatal antibiotic exposure and subsequent atopy. Am J Respir Crit Care Med. 2003;167:1578–9.
161. McKeever TM, Lewis SA, Smith C, Hubbard R.The importance of prenatal exposures on the develop­ment of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med. 2002;166:827–32.
162. Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review. Br J Dermatol. 2013;169:983–91.
163. Stensballe J, Jensen SM, etal. Use of antibiotics dur­ing pregnancy increases the risk of asthma in early childhood. J Pediatr. 2013;162:832–8.
164. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51:1–22.
112
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
165. Plessinger MA, Woods JR Jr, Miller RK.Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acidinduced damage. Am J Obstet Gynecol. 2000;183:979–85.
166. Wideman GL, Bolding OT, Baird GH.Ascorbic acid deciency and premature rupture of membranes. Am J Obstet Gynecol. 1964;88:592–5.
167. Woods JR Jr, Plessinger MA, Miller R.Vitamins C and E: missing links in preventing preterm prema­ture rupture of membranes? Am J Obstet Gynecol. 2001;185:5–10.
168. Rumbold CA, Haslam RR, etal. Vitamins C and E and the risks of preeclampsia and perinatal compli­cations. N Engl J Med. 2006;354:1796–806.
169. Huhle G, Geberth M, Hoffmann U, Heene DL, Harenberg J. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. Gynecol Obstet Invest. 2000;49:67.
170. Testa L, Andreotti F, Biondi Zoccai GGL, Burzotta F, Bellocci F, Crea F.Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients. Int J Cardiol. 2007;122:117.
171. Elovitz MA, Saunders T, Ascher-Landsberg J, Phillippe M.Effects of thrombin on myometrial con­tractions invitro and invivo. Am J Obstet Gynecol. 2000;183:799.
172. Zhou SS, Tao YH, Huang K, Zhu BB, Tao FB. Vitamin D and risk of preterm birth: up-to­date meta-analysis of randomized controlled trials and observational studies. J Obstet Gynaecol Res. 2017;43(2):247–56.
173. Hoffman ES, Suzuki M. No Title. West J Surg. 1949;57:150.
174. Cosgrove S. Surgical complications of pregnancy. Am J Obstet Gynecol. 1937;34:469–79.
175. De Voe RW, Ferris DO, Day LA.Pregnancy at term complicated by ruptured appendix. Mayo Clin Proc. 1947;22:135–41.
176. Gates P, Davis LJ, Brocklehurst P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2002;2:CD001689.
177. Gomez R, Medina L, etal. Cervicovaginal bronec­tin improves the prediction of preterm delivery based on sonographic cervical length in patients with pre­term uterine contractions and intact membranes. Am J Obstet Gynecol. 2005;192:350–9.
178. Finnstrom PO, Sedin G, etal. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr. 1997;86:503–11.
179. Haas DM, Kirkpatrick P, etal. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345:e6226.
180. Yilmaz Y, Bac B, et al. Acute appendicitis in pregnancy—risk factors associated with princi­pal outcomes: a case control study. Int J Surg. 2007;5(3):192–7.
181. Creasy R.Preventing preterm birth. N Engl J Med. 1991;325:727–8.
182. Kort B, Watson WJ, Katz VL.The effect of nonob­stetric operation during pregnancy. Surg Gynecol Obstet. 1993;177:371–6.
183. Doberneck R.Appendectomy during pregnancy. Am Surg. 1985;51(5):265–8.
184. Hée P, Viktrup L. The diagnosis of appendici­tis during pregnancy and maternal and fetal out­come after appendectomy. Int J Gynecol Obstet. 1999;65(2):129–35.
185. Caritis SN, Chan L, Darby MJ. Pharmacological treatment of preterm labor. Clin Obstet Gynecol. 1988;3:635–51.
186. Zhang Y, Zhao YY, Qiao J, Ye RH. Diagnosis of appendicitis during pregnancy and perinatal out­come in the late pregnancy. Chin Med J (Engl). 2009;122:521–4.
187. Toth M, Witkin SS, Ledger W, Thaler H. The role of infection in the etiology of preterm birth. Obstet Gynecol. 1988;71:723–6.
188. El-Amin Ali M, Zaki ZM, etal. Acute abdomen in pregnancy. Int J Gynaecol Obstet. 1998;62:31–6.
189. Kupferming M, Yaron Y, Peyser MR, Lessing JB. Nifedipine versus ritodrine for suppression of preterm labor. BJOG. 1993;100:1090–4.
190. Ferguson DC, Holbrook RH, et al. Cardiovascular and metabolic effects associated with nifedip­ine and ritodrine tocolysis. Am J Obstet Gynecol. 1989;161:788–95.
191. Read MD, Wellby DE.The use of calcium antago­nist nifedipine to suppress preterm labor. BJOG. 1986;93:504–18.
192. Meyer WR, Graves WL, Randall HW. Nifedipine versus ritodrine for suppression or preterm labor. J Reprod Med. 1990;35:649–53.
193. Lu MJ, El-Sayed YY, Kirkwood KS, etal. Medical versus surgical management of biliary tract disease in pregnancy. Am J Surg. 2004;188:755–9.
194. Sungler PM, Steiner H, et al. Laparoscopic chole­cystectomy and interventional endoscopy for gall­stone complications during pregnancy. Surg Endosc. 2000;14:267–71.
195. Stelzl P, Kehl S, Rath W. Maintenance tocolysis: a reappraisal of clinical evidence. Arch Gynecol Obstet. 2019;300:1189.
196. Brookeld KF, Su F, Elkomy MH, Drover DR, Lyell DJ, Carvalho B. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 2016;214(6):737.e1–9.
197. Pearlman MD, Lorenz RP, Tintinalli JE. A pro­spective controlled study of the outcome after trauma during pregnancy. Am J Obstet Gynecol. 1990;162:1502–10.
198. Pak EA, Chan LLR.Is adverse pregnancy outcome predictable after blunt abdominal trauma? Am J Obstet Gynecol. 1998;179:1140–4.
199. Chollat C, Sentilhes L, Marret S. Fetal neuropro­tection by magnesium sulfate: from translational
References
https://t.me/medicina_free
113
research to clinical application. Front Neurol. 2018;9:247.
200. Hallak M, Berry S, Madincea F, Romero R, Evans M, Cotton D.Fetal serum and amniotic uid magne­sium concentrations with maternal treatment. Obstet Gynecol. 1993;81(2):185–8.
201. Hanson B, Tabbarah R. Preterm Delivery in the Setting of Left Calyceal Rupture. Case Rep Obstet Gynecol. 2015;2015:906073.
202. Jokar A, Cyrus A, Babaei M, Taheri M, Almasi­Hashiani A, Behzadinia E, etal. The effect of magne­sium sulfate on renal colic pain relief; a randomized clinical trial. Emerg (Tehran). 2017;5:e25.
203. Meyer JL, Smith LH. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol. 1975;13:36–9.
204. Ross AE, Handa S, Lingeman JE, Matlaga BR. Kidney stones during pregnancy: an inves­tigation into stone composition. Urol Res. 2008;36(2):99–102.
205. Al-Qudah M. Postpartum pain due to thrombosed varicose veins of the round ligament of the uterus. Postgrad Med J. 1993;69:820–1.
206. Mathew M, Jesrani SK, Mubarak SA.Conservative management of twisted ischemic adnexa in early pregnancy. Ann Med Health Sci Res. 2015;5:142–4.
207. Duncan RP, Shah MM.Laparoscopic salpingectomy for isolated fallopian tube torsion in the third trimes­ter. Case Rep Obstet Gynecol. 2012;2012:239352.
208. Dodd JM, Flenady V, Cincotta R, Crowther CA.Prenatal administration of progesterone for pre­venting preterm birth. Cochrane Database Syst Rev. 2006;1:CD004947.
209. Besinger JR, Keyes WG, Johnson TR, et al. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol. 1991;164:981–6; dis­cussion 986-988.
210. Kurki M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol. 1991;78:1093–7.
211. Norton J, Cooper BA, etal. Neonatal complications after the administration of indomethacin for preterm labor. New Engl. J Med. 1993;329:1602–7.
212. Moise JK. The effect of advancing gestational age on the frequency of fetal ductal constriction sec­ondary to maternal indomethacin use. Am J Obstet Gynecol. 1993;168:1350–3.
213. Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal out­comes. Am J Obstet Gynecol. 2007;197(486):e1–10.
214. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ.Tocolysis with indomethacin increases the inci­dence of necrotizing enterocolitis in the low-birth­weight neonate. Am J Obstet Gynecol. 1994;170(1 Pt 1):102–6.
215. Gross T, Vogt S, etal. Inhibition of cyclooxygenase­ 2 prevents inammation-mediated preterm labor
in the mouse. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1415–23.
216. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inam­matory bowel disease following exposure to 5- aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol. 2008;25:271–5.
217. Adams Waldorf D, etal. Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide­induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci. 2008;15:121–7.
218. Li L, Lei W, Kang J.Role of Toll-like receptor 4in inammation-induced preterm delivery. Mol Hum Reprod. 2010;16:267–72.
219. Hawkins LD, Christ WJ, Rossignol DP.Inhibition of endotoxin response by synthetic TLR4 antagonists. Curr Top Med Chem. 2004;4:1147–71.
220. Matsunaga N, Matsumoto T, Ii MNT. TAK-242 (resatorvid), a small-molecule inhibitor of Toll­like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol. 2011;79:34–41.
221. Djokanovic C, Pupco A, Koren G. Safety of inf­liximab use during pregnancy. Reprod Toxicol. 2011;32:93–7.
222. Nielsen OH, Loftus EV Jr, Jess T.Safety of TNF­alpha inhibitors during IBD pregnancy: a systematic review. BMC Med. 2013;11:174.
223. di Meglio P, Ianaro A, Ghosh S.Amelioration of acute inammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappa B acti­vation. Arthritis Rheum. 2005;52:951–8.
224. Underwood RR, Kotzer CJ, et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inam­matory cytokine production, airways eosinophil inltration, and persistence. J Pharmacol Exp Ther. 2000;293:281–8.
225. Ward JW, Azzarano LM, etal. SB-239063, a potent and selective inhibitor of p38 map kinase: preclinical pharmacokinetics and species-specic reversible isomerization. Pharm Res. 2001;18:1336–44.
226. Ng PY, Ireland DJ, Keelan JA. Drugs to block cytokine signaling for the prevention and treat­ment of inammation-induced preterm birth. Front Immunol. 2015;6:166.
227. Bariani MV, Correa F, Leishman E, Domínguez Rubio AP, Arias A, Stern A, etal. Resveratrol pro­tects from lipopolysaccharide-induced inamma­tion in the uterus and prevents experimental preterm birth. Mol Hum Reprod. 2017;23(8):571–81.
228. Kim IQ, Marikawa Y. Embryoid body test with morphological and molecular endpoints implicates potential developmental toxicity of trans-resveratrol. Toxicol Appl Pharmacol. 2018;355:211–25.
229. Dan J, Koller M, etal. Iatrogenic mechanical ileus due to over-distended uterus. Gynecol Obstet Invest. 1988;25:143–4.
114
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
230. Bryan WJ. Surgical emergencies in pregnancy and in the puerperium. Am J Obstet Gynecol. 1955;70:1204–11.
231. Ingemarsson I. Tocolytic therapy and clini­cal experience. Combination therapy. BJOG. 2005;112(Suppl):89–93.
232. Smith MC, Ohlsson A, et al. Randomized double blind placebo controlled trial of transdermal nitro­glycerin for preterm labor. Am J Obstet Gynecol. 2007;196(37):e1–8.
233. Roberts D, Dalziel S.Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454.
234. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, etal. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162.
235. Harrison MS, Goldenberg RL.Global burden of pre­maturity. Semin Fetal Neonatal Med. 2016;21:74.
236. McCormick M.The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985;312:82–90.
237. Peacock JL, Marston L, Marlow N, Calvert SA, Greenough A. Neonatal and infant outcome in boys and girls born very prematurely. Pediatr Res. 2012;71:305–10.
238. Shah BA, Padbury JF. Neonatal sepsis an old prob­lem with new insights. Virulence. 2014;5:170.
239. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low­birth- weight infants with neonatal infection. JAMA. 2004;292:2357.
240. Mitha A, Foix-L’Helias L, Arnaud C, Marret S, Vieux R, Aujard Y, et al. Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants. Pediatrics. 2013;132:e372.
241. Goldenberg RL, Andrews WW, Goepfert AR, Faye­Petersen O, Cliver SP, Carlo WA, etal. The Alabama Preterm Birth Study: umbilical cord blood urea­plasma urealyticum and mycoplasma hominis cul­tures in very preterm newborn infants. Am J Obstet Gynecol. 2008;198(1):43.e1.
242. Andrews WW, Goldenberg RL, Faye-Petersen O, et al. The Alabama Preterm Birth study: polymor­phonuclear and mononuclear cell placental inltra­tions, other markers of inammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006;195:803–8.
243. Gotsch F, Romero R, Kusanovic J, etal. The fetal inammatory response syndrome. Clin Obstet Gynecol. 2007;50:652–83.
244. Gomez R, Romero R, Ghezzi F, et al. The fetal inammatory response syndrome. Am J Obstet Gynecol. 1998;179:194–202.
245. Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm
labour with intact membranes. Cochrane Database Syst Rev. 2013;(12):CD000246.
246. Dinarello CA, Simon A, van der Meer JWM.Treating inammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633.
247. Girard S, Tremblay L, Lepage M, Sébire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inammation. J Immunol. 2010;184(7):3997–4005.
248. Findley P. Appendicitis complicating pregnancy. JAMA. 1912;59:612–4.
249. Wilson R. Acute appendicitis complicating preg­nancy, labor and the puerperium. Surg Gynecol Obstet. 1927;45:620–8.
250. Andersen AM, Vastrup P, Wohlfahrt J, etal. Fever in pregnancy and risk of fetal death: a cohort study. Lancet. 2002;360:1552–6.
251. Kovo M, Gonen N, Schreiber L, Hochman R, Noy LK, Levy M, etal. Histologic chorioamnionitis con­comitant placental abruption and its effects on preg­nancy outcome. Placenta. 2020;94:39–43.
252. Hansen-Pupp AL, Hellström-Westas L, et al. Inammation at birth is associated with subnormal development in very preterm infants. Pediatr Res. 2008;64:183–8.
253. Khwaja O, Volpe JJ.Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed. 2008;93:F153–61.
254. Wu Y. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev. 2002;8:25–9.
255. Kaukola T, Herva R, Perhomaa M, etal. Population cohort associating chorioamnionitis, cord inam­matory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res. 2006;59:478–83.
256. Redline RW, Minich N, Taylor HG, Hack M.Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg). Pediatr Dev Pathol. 2007;10:282–92.
257. Suppiej A, Franzoi M, Vedovato S, et al. Neurodevelopmental outcome in preterm his­tological chorioamnionitis. Early Hum Dev. 2009;85:187–9.
258. Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specic patho­genesis via perinatal inammation? Pediatr Res. 2011;69:26R–33R.
259. Li J, Ramenaden ER, Peng J, Koito H, Volpe JJ, Rosenberg PA. Tumor necrosis factor mediates lipopolysaccharide- induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci. 2008;28:5321.
260. Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA. 2000;284:1417–24.
261. Yanowitz TD, Jordan JA, Gilmour C, et al. Hemodynamic disturbances in premature infants
References
https://t.me/medicina_free
115
born after chorioamnionitis: association with cord blood cytokine concentrations. Pediatr Res. 2002;51:310–6.
262. Romero R, Espinoza J, Gonçalves L, et al. Fetal cardiac dysfunction in preterm premature rup­ture of membranes. J Matern Fetal Neonatal Med. 2004;16:146–57.
263. Hansen-Pupp I, Hallin AL, Hellström-Westas L, et al. Inammation at birth is associated with sub­normal development in very preterm infants. Pediatr Res. 2008;64:183–8.
264. Yanowitz TD, Baker RW, Roberts JM, Brozanski BS. Low blood pressure among very-low-birth­weight infants with fetal vessel inammation. J Perinatol. 2004;24:299–304.
265. Yanowitz T. Cerebrovascular autoregulation among very low birth weight infants. J Perinatol. 2011;31:689–91.
266. Yoon CJ, Romero R, etal. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997;177:797–802.
267. Nitsos SM, Duncan J, et al. Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J Soc Gynecol Investig. 2006;13:239–47.
268. Duncan ML, Suzuki K, et al. Chronic endotoxin exposure causes brain injury in the ovine fetus in the absence of hypoxemia. J Soc Gynecol Investig. 2006;13:87–96.
269. Cai ZL, Pang Y, etal. Cytokine induction in fetal rat brains and brain injury in neonatal rats after mater­nal lipopolysaccharide administration. Pediatr Res. 2000;47:64–72.
270. Strigini FAL, Cioni G, Canapicchi R, Nardini V, Capriello P, Carmignani A. Fetal intracranial hemorrhage: is minor maternal trauma a possible pathogenetic factor? Ultrasound Obstet Gynecol. 2001;18(4):335–42.
271. Leroy-Malherbe V, Bonnier C, Papiernik E, Groos E, Landrieu P.The association between developmental handicaps and traumatic brain injury during preg­nancy: an issue that deserves more systematic evalu­ation. Brain Inj. 2006;20(13–14):1355–65.
272. Baethmann M, Kahn T, Lenard HG, Voit T. Fetal CNS damage after exposure to maternal trauma dur­ing pregnancy. Acta Paediatr. 1996;85(11):1331–8.
273. Little WJ.On the inuence of abnormal parturition, difcult labours, premature births and asphyxia neo­natorum on the mental and physical condition of the child, especially in relation to deformities. Trans Obstet Soc London. 1861;3:293–344.
274. Eastman N, Deleon M. The etiology of cerebral palsy. Am J Obstet Gynecol. 1955;69:950–61.
275. Easton A. Acute appendicitis during pregnancy. Postgrad Med J. 1957;33:272–7, 286.
276. Naeye RL. Causes of perinatal mortality in the US Collaborative Perinatal Project. JAMA. 1977;238:228.
277. Redelmeier DA, Naqib F, Thiruchelvam D, Barrett JF. Motor vehicle crashes during pregnancy and
cerebral palsy during infancy: a longitudinal cohort analysis. BMJ Open. 2016;6:e011972.
278. Muench MV, Baschat AA, Reddy UM, Mighty HE, Weiner CP, Scalea TM, etal. Kleihauer-Betke test­ing is important in all cases of maternal trauma. J Trauma Injury Infect Cri Care. 2004;57:1094–8.
279. Hayes B, Ryan S, Stephenson JBP, King MD.Cerebral palsy after maternal trauma in preg­nancy. Dev Med Child Neurol. 2007;49:700.
280. Raju TN.Historical perspectives on the etiology of cerebral palsy. Clin Perinatol. 2006;33(2):233–50.
281. Chang BS, Lowenstein DH.Epilepsy. N Engl J Med. 2003;349:1257–66.
282. Guerrini R. Epilepsy in children. Lancet. 2006;367:499–524.
283. Hauser W.The prevalence and incidence of convul­sive disorders in children. Epilepsia. 1994;35(Suppl
2):S1–6.
284. Whitehead L, Joseph KS, et al. Relation of preg­nancy and neonatal factors to subsequent develop­ment of childhood epilepsy: a population-based cohort study. Pediatrics. 2006;117:1298–306.
285. Procopio M, Marriott PK. Seasonality of birth in epilepsy: a Danish study. Acta Neurol Scand. 1998;98:297–301.
286. Procopio M, Davies RJE, Marriott PK.Seasonality of birth in epilepsy: a Southern Hemisphere study. Seizure. 2006;15:17–21.
287. Sun M, Christensen J, et al. Prenatal exposure to maternal infections and epilepsy in child­hood: a population-based cohort study. Pediatrics. 2008;121:e1100–7.
288. Nørgaard V, Nielsen RB, etal. Maternal use of antibi­otics, hospitalisation for infection during pregnancy, and risk of childhood epilepsy: a population-based cohort study. PloS One. 2012;7:e30850.
289. Sun Y, Vestergaard M, Christensen J, Olsen J. Prenatal exposure to elevated maternal body temperature and risk of epilepsy in childhood: a population- based pregnancy cohort study. Paediatr Perinat Epidemiol. 2011;25:53–9.
290. Fabene PF, Constantin G, Bramanti P.The emerging role for chemokines in epilepsy. J Neuroimmunol. 2010;224:22–7.
291. Vezzani A, Granata T. Brain inammation in epi­lepsy: experimental and clinical evidence. Epilepsia. 2005;46:1724–43.
292. Lieberman E, Mathur G, et al. Intrapartum fever and unexplained seizures in term infants. Pediatrics. 2000;106:983–8.
293. Slattery MM, Morrison JJ.Preterm delivery. Lancet. 2002;360:1489–97.
294. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR, etal. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age follow­ing extremely preterm birth. Arch Dis Child Fetal Neonatal Ed. 2005;90(2):F134–40.
295. Petrou S, Mehta Z, Hockley C, Cook-Mozaffari P, Henderson J, Goldacre M. The impact of preterm
116
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
birth on hospital inpatient admissions and costs dur­ing the rst 5 years of life. Pediatrics. 2003;112(6 Pt
1):1290–7.
296. Shennan AH, Bewley S.Why should preterm births be rising? BMJ. 2006;332(7547):924–5.
297. Huddy CL, Johnson A, Hope PL.Educational and behavioural problems in babies of 32-35 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;85(1):F23–8.
298. Bartley M, Power C, Blane D, Smith GD, Shipley M.Birth weight and later socioeconomic disadvan­tage: Evidence from the 1958 British cohort study. Br Med J. 1994;309(December):1475–8.
299. Saigal S, Stoskopf B, Streiner D, Boyle M, Pinelli J, Paneth N, et al. Transition of extremely low­birth- weight infants from adolescence to young adulthood: comparison with normal birth-weight controls. JAMA. 2006;295(6):667–75.
300. Davey Smith C, Ferrell C, et al. Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. BMJ. 1997;315(7117):1189–93.
301. Melamed N, Aviram A, Silver M, Peled Y, Wiznitzer A, Glezerman M, et al. Pregnancy course and outcome following blunt trauma. J Matern Fetal Neonatal Med. 2012;25(9):1612–7.
302. McFarlane J, Parker B, Soeken K. Abuse during pregnancy: associations with mater­nal health and infant birth weight. Nurs Res. 1996;45:37–42.
303. Curry MA, Perrin N, Wall E. Effects of abuse on maternal complications and birth weight in adult and adolescent women. Obstet Gynecol. 1998;92(4I):530–4.
304. Fernandez FM, Krueger PM. Domestic violence: effect on pregnancy outcome. J Am Osteopath Assoc. 1999;99(5):254–6.
305. Berenson AB, Wiemann CM, Wilkinson GS, Jones WA, Anderson GD.Perinatal morbidity associated with violence experienced by pregnant women. Am J Obstet Gynecol. 1994;170(6):1760–9.
306. Dye TD, Tollivert NJ, Lee RV, Kenney CJ.Violence, pregnancy and birth outcome in Appalachia. Paediatr Perinat Epidemiol. 1995;9(1):35–47.
307. Amaro H, Fried LE, Cabral H, Zuckerman B. Violence during pregnancy and substance use. Am J Public Health. 1990;80(5):575–9.
308. Campbell J, Torres S, Ryan J, King C, Campbell DW, Stallings RY, et al. Physical and nonphysi­cal partner abuse and other risk factors for low
birth weight among full term and preterm babies: a multiethnic case-control study. Am J Epidemiol. 1999;150(7):714–26.
309. Tinker SC, Reefhuis J, Dellinger AM, Jamieson DJ. Maternal injuries during the periconceptional period and the risk of birth defects, National Birth Defects Prevention Study, 1997-2005. Paediatr Perinat Epidemiol. 2011;25:487–96.
310. Tinker SC, Reefhuis J, Dellinger AM, Jamieson DJ.Epidemiology of maternal injuries during preg­nancy in a population-based study, 1997–2005. J Womens Health. 2010;19(12):2211–8.
311. Schiff M, Daling JR. Pregnancy-associated injury hospitalizations: maternal and fetal outcomes. Paediatr Perinat Epidemiol. 2001;15:A29.
312. Carmichael SL, Shaw GM. Maternal life event stress and congenital anomalies. Epidemiology. 2000;11(1):30–5.
313. Carmichael SL, Shaw GM, Yang W, Abrams B, Lammer EJ.Maternal stressful life events and risks of birth defects. Epidemiology. 2007;18(3):356–61.
314. Honein MA, Rasmussen SA, Reefhuis J, Romitti PA, Lammer EJ, Sun L, et al. Maternal smok­ing and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology. 2007;18(2):226–33.
315. Clarren SK, Alvord EC, Sumi SM, Streissguth AP, Smith DW.Brain malformations related to prenatal exposure to ethanol. J Pediatr. 1978;92(1):64–7.
316. Beversdorf D. Stress during pregnancy linked to autism. San Diego: Society for Neuroscience; 2001.
317. Ayer JB. Case of eclampsia before and after labor, followed by peritonitis, fatal on the fourteenth day. Boston Med Surg J. 1871;7(4):53–5.
318. Konje J, Taylor D. Bleeding in late pregnancy. In: James D, Steer P, Weiner C, Gonik B, editors. High Risk Pregnancy. 3rd ed. Edinburgh: WB Saunders;
2006. p.1259–75.
319. Rasmussen S, Irgens LM, Dalaker K. The effect on the likelihood of further pregnancy of placen­tal abruption and the rate of its recurrence. BJOG. 1997;104:1292–5.
320. Pritchard JA.Fetal death in utero. Obstet Gynecol. 1959;14:573–80.
321. Wilasrusmee C, Sukrat B, McEvoy M, Attia J, Thakkinstian A.Systematic review and meta-analy­sis of safety of laparoscopic versus open appendi­cectomy for suspected appendicitis in pregnancy. Br J Surg. 2012;99(11):1470–8.
Fetal Trauma
https://t.me/medicina_free
5
Abstract
The fetus can sustain mechanical trauma dur­ing pregnancy or difcult delivery. Approximately 2% of all live births in the USA were exposed to intrauterine trauma from motor vehicle accidents. Blunt fetal trauma during pregnancy can result in (1) fetal/neonatal death, (2) direct fetal injury, and (3) deceleration injury. It can be detected dur­ing maternal imaging diagnostics, CTG moni­toring, or delivery. It can also be the result of childbirth trauma. It is imperative to detect intrauterine trauma because, in many cases, it indicates Cesarean delivery to minimize addi­tional trauma during difcult or prolonged vaginal delivery. The fetal outcome depends on the underlying fetal, amniotic, and uterine injuries. Penetrating fetal trauma accounts for 10% of all fetal trauma. With penetrating trauma, primarily stab injuries in the second half of pregnancy, maternal injuries are mini­mal due to the protective role of the pregnant uterus. Consequently, fetal penetrating trauma is common. With stabbing fetal trauma, mor­tality is minimal, with the potential for various degrees of impairment. On the contrary, gun­shot trauma has high fetal mortality from direct fetal trauma or indirectly from severe maternal bleeding.
5.1 Fetal Physiology
During the rst week, the conceptus has not yet been implanted in the uterus, making it relatively resistant to injury. Soon after, the embryo attaches to the uterus via the anchoring villi. The placenta is not as elastic as the myometrium, potentially lead­ing to shear stresses and disruption of the villi with force applied to the uterus. The fetus’s well-being depends on the adequacy of the maternal blood ow to the placenta, mainly derived from the uter­ine arteries. The uterine vascular bed is a low resis­tance system, not capable of further dilation and devoid of autoregulation. Therefore, placental blood ow varies directly with the net perfusion pressure (uterine artery pressure-uterine venous pressure) across the intervillous space and inversely with uterine vascular resistance. In normal preg­nancy, the fetus has a considerable functional reserve to withstand uterine blood ow or oxygen­ation changes. In sheep, fetal oxygen consumption does not decrease until oxygen delivery is reduced by 50% [1]. Later in pregnancy, vital fetal organs such as the brain and myocardium are further pro­tected by the “diving reex,” which allows redistri­bution of fetal cardiac output during maternal hypoxemia or compromised uterine perfusion. The fetus’s response to these insults is limited and seems to vary with gestational age. Decreased pla­cental blood ow quickly leads to fetal distress.
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_5
117